ANTIOXIDANT THERAPEUTIC ACTIONS OF MEDICINAL PHYTOCHEMICALS, SILYMARIN AND SILIBININ, ON STREPTOZOTOCIN DIABETIC RATS: FIRST NOVEL COMPARATIVE ASSESSMENT OF STRUCTURAL RECOVERIES OF HISTOLOGICAL AND ULTRASTRUCTURAL CHANGES ON ISLETS OF LANGERHANS, Î’-CELLS, MITOCHONDRIA AND NUCLEUS
Objective: We studied correlation between antioxidant properties of Silymarin and Silibinin and the restoration and recovery of normal structure of islets of Langerhans Î²-cells and mitochondria in Streptozotocin-diabetic rats.
Methods: Rats rendered diabetic and one week after diabetes induction, rats received orally Silymarin or Silibinin (100 mg/Kg). Biochemical parameters: glucose, HbA1c, lipid profile, hepatic SOD, GSH and MDA were determined. Furthermore, changes in islets of Langerhans, Î²-cells as well as mitochondria were recorded using electron microscope.
Results: 1) Silymarin and Silibinin treatment(s) of STZ-diabetic rats can correct and reverse the imbalance between ROS and antioxidant defense by restoring and augmentation of its capacity by significantly increasing SOD, GSH and modulating lipid peroxidation (by significantly decreasing MDA). 2) We provided evidence, using EM technique, to prove that hypoglycemic/antidiabetic/therapeutic actions of both Silymarin and Silibinin (by improving significantly both glucose and insulin levels), may be due to their ability to stimulate Î²-cells to secrete insulin through restoring antioxidant endogenous properties and hence, recovery of intact insulin secretory granules as well as restoration of normal structure of pancreatic endocrine cell islets of Langerhans. 3) We provided first novel comparative assessment of histological and ultrastructural changes on islets of Langerhans and Î²-cells as well as complete mitochondrial recovery by oral Silymarin and Silibinin treatment (s) in diabetic rats.
Conclusion: Both agents show Hypoglycemic, hpolipidemic and antioxidant properties, exhibit structural recovery of mitochondria, intact insulin secreting granules and nucleus, they act as anti-mitochondrial loss and/or dysfunction in diabetes.
Keywords: Silymarin, Silibinin, Diabetes, Antidiabetic agents, Antioxidants, Electron Microscope, Mitochondrial and Î²-cells Recovery
American-Diabetes-Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010;33(Suppl 1): S62â€“S69.
Reasner CA. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. J Cardiovasc Pharmacol 2008;52:136-44.
Nishikawa T, Araki, E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signaling 2007;9:343-53.
Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biol Med 1991;10:339-52.
Lyons TJ. Oxidized low-density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes? Diabet Med 1991;8:411-9.
Velazquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabetic Med 1991;8:752-8.
Opara EC. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Health 2002;122:28-34.
Valeron PF, de Pablos-Velasco PL. Limitations of insulin-dependent drugs in the treatment of type 2 diabetes mellitus. Med Clin (Barc) 2013;141(Suppl 2):20-5.
Bell DS, Patil HR, O'Keefe JH. Divergent effects of various diabetes drugs on cardiovascular prognosis. Rev Cardiovasc Med 2013;14:e107-22.
Asgary S, Naderi GA, Zadegan NS, Vakili R. The inhibitory effects of pure flavonoids on in vitro protein glycosylation. J Herb Pharmacother 2002;2:47-55.
Lin YM, Zhou Y, Flavin M, Zhou LM, Nie W, Chen FC. Chalcones and flavonoids as anti-tuberculosis agents. Bioorg Med Chem 2002;10:2795-802.
Go ML, Wu X, Liu XL. Chalcones: an update on cytotoxic and chemoprotective properties. Curr Med Chem 2005;12:483-99.
Nowakowska Z. A Review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007;42:125-37.
Hassanein H, Abdel-Mohsen M, Shams K, Abdel-azim N, Saleh M, Ehsan N, et al. Comparative analysis of the biological activity of Silybum marianum l. Food supplements available on the market: in vitro study. Int J Pharm Pharm Sci 2015;7:55-60.
Wianowska D, Wisniewski M. Simplified procedure of silymarin extraction from silybum marianum L. gaertner. J Chromatogr Sci 2015;53:366-72.
Colturato CP, Constantin RP, Maeda AS Jr, Yamamoto NS, Bracht A, Ishii-Iwamoto EL, et al. Metabolic effects of silibinin in the rat liver. Chem Biol Interact 2011;195:119-32.
Abdollahi P, Ebrahimi M, Motamed N, Samani FS. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468. Anticancer Drugs 2015;26:487-97.
Haddad Y, Vallerand D, Brault A, Haddad PS. Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. J Evidence-Based Complementary Altern Med eCAM. 2011. Doi:10.1093/ecam/nep164. [Epub 12 Jan 2011]
Sheela N, Jose MA, Sathyamurthy D, Kumar BN. Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. Iran J Kidney Dis 2013;7:117-23.
Detaille D, Sanchez C, Sanz N, Lopez-Novoa JM, Leverve X, El-Mir MY. Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perfused rat hepatocytes. Life Sci 2008;82:1070â€“6.
Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M. Long-term (12 mo) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol 1997;26:871â€“9.
Montilla P, Barcos M, Munoz MC, Munoz-Castaneda JR, Bujalance I, Tunez I. Protective effect of montilla-moriles appellation red wine on oxidative stress induced by streptozotocin in the rat. J Nutr Biochem 2004;15:688-93.
Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969;6:24-7.
Beutler E, Duron O, Kelly MB. Determination of blood glutathione. J Lab Clin Med 1963;61:882.
Hanas R, John G. consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Diabet Med 2010;27:737-8.
Draper W, Hadley M. Indirect determination of oxygen free radical. Methods Enzymol 1990;86:421-31.
Nishikimi M, Roa NA, Yogi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophy Res Commun 1972;46:849-54.
Meiattini F, Prencipe L, Bardelli F, Giannini G, Tarli P. The 4-hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol. Clin Chem 1978;24:2161-5.
Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-82.
Grove TH. Effect of reagent pH on the determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium. Clin Chem 1979;25:560-4.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
Weesner FM. General zoological microtechniques. Huntington, N Y: Robert E. Krieger Publ. Co.; 1970. p. 230.
Reynolds ES. The use of lead citrates at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 1963;17:208-12.
Holt R, Cockram C, Flyvbjerg A, Goldstein B. Textbook of diabetes. 4th ed./edited by/edited by. Holt R, Cockram C, Flyvbjerg A, Goldstein B. ed. Oxford: Wiley-Blackwell; 2010.
Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res/Academia Scientiarum Bohemoslovaca. 2001;50:537-46.
Beppu H, Shimpo K, Chihara T, Kaneko T, Tamai I, Yamaji S, et al. Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components. J Ethnopharmacol 2006;103:468-77.
Dutta M, Ghosh A, Rangari V, Jain G, Khobragade S, Chattopadhyay A, et al. Silymarin protects against copper-ascorbate induced injury to goat cardiac mitochondria in vitro: involvement of antioxidant mechanism(s). Int J Pharm Pharm Sci 2014;6:422-9.
Skottova N, Krecman V. Silymarin as a potential hypocholesterolemic drug. Physiol Res 1998;47:1-7.
Jadhav G, Upasani D. Effect of silymarin on DOCA salt streptozotocin-induced diabetic hypertension in unilaterally nephrectomized rats. Int J Pharm Res 2011;1:27-32.
El-Far M, Negm A, Wahdan M. Promising biopharmaceutical use of silymarin and silibinin as natural antidiabetic agents in streptozotocin-induced diabetic rats: a first comparative assessment. World J Pharm Pharm Sci 2015;4:7-28.
Abenavoli L, Gabriella A, Raffaele C, Natasa M, Francesco C. Milk thistle for the treatment of nonalcoholic fatty liver disease. Hepatic Mon 2011;11:173-7.
Chen B, Bestetti G, Day RM, Turner AP. The synthesis and screening of a combinatorial peptide library for affinity ligands for glycosylated hemoglobin. Biosens Bioelectron 1998; 13:779-85.
Sridhar SB, Sheetal UD, Pai MR, Shastri MS. Preclinical evaluation of the antidiabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats. Braz J Med Biol Res 2005;38:463-8.
Pari L, Latha M. Effect of cassia auriculata flowers on blood sugar levels, serum and tissue lipids in streptozotocin diabetic rats. Singapore Med J 2002;43:617-21.
Agardh CD, Bjorgell P, Nilsson-Ehle P. The effects of tolbutamide on lipoproteins, lipoprotein lipase and hormone-sensitive lipase. Diabetes Res Clin Pract 1999;46:99-108.
Ahmed I, Lakhani MS, Gillett M, John A, Raza H. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2001;51:155-61.
El-Khawaga OY, Abou-Seif M, El-Waseef A, Negm A. Hypoglycemic, hypolipidemic and antioxidant activities of cleome droserifolia in streptozotocin-diabetic rats. J Stress Physiol Biochem 2010;6:28-41.
El-Far M, Gabr M, El-Halawani S, Ibrahim R, Khater S, Refaie A, et al. Novel evidence of restoring and augmenting antioxidant defense after treatment of diabetic rats using stem cells. Curr Topics Biochem Res 2012;14:25-37.
Gabr M, El-Far M, Ibrahim R, El-Halawani S, Ismail A, Zakaria M, et al. Biochemical induction of adult bone marrow hematopiotic stem cells into insulin-producing cells. Curr Top Biochem Res 2012;14:45-56.
Arai K, Iizuka S, Tada Y, Oikawa K, Taniguchi N. Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochim Biophys Acta 1987;924:292-6.
Ananthan R, Baskar C, Narmatha Bai V, Pari L, Latha M, Ramkumar KM. Antidiabetic effect of gymnema montanum leaves: effect on lipid peroxidation induced oxidative stress in experimental diabetes. Pharmacol Res 2003;48:551-6.
Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1987;1:441-5.
Soto CP, Perez BL, Favari LP, Reyes JL. Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp Biochem Physiol Part C: Pharmacol Toxicol Endocrinol 1998;119:125-9.
Adewole SO, Caxton-Martins EA, Ojewole JA. Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr J Tradit Complementary Altern Med 2006;4:64-74.
Motshakeri M, Ebrahimi M, Goh YM, Othman HH, Hair-Bejo M, Mohamed S. Effects of brown seaweed (Sargassum polycystum) extracts on kidney, liver, and pancreas of type 2 diabetic rat model. J Evidence-Based Complementary Altern Med 2014. doi.org/10.1155/2014/379407. [Article in Press]
Vengerovskii AI, Khazanov VA, Eskina KA, Vasilyev KY. Effects of silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus. Bull Exp Biol Med 2007;144:53-6.
Bouderba S, Sanchez-Martin C, Villanueva GR, Detaille D, Koceir EA. Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in psammomys obesus, a relevant animal model of human obesity and diabetes. J Diabetes 2014;6:184-92.
Duan WJ, Li QS, Xia MY, Tashiro S, Onodera S, Ikejima T. Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways. Biol Pharm Bull 2011;34:47-53.
Pushparaj P, Tan CH, Tan BK. Effects of averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J Ethnopharmacol 2000;72:69-76.
Arulselvan P, Subramanian SP. Beneficial effects of murraya koenigii leaves on antioxidant defense system and ultra structural changes of pancreatic beta-cells in experimental diabetes in rats. Chem Biol Interact 2007;165:155-64.
Cardinal JW, Allan DJ, Cameron DP. Differential metabolite accumulation may be the cause of strain differences in sensitivity to streptozotocin-induced beta cell death in inbred mice. Endocrinology 1998;139:2885-91.
Daryl K, Granner MD. Hormones of the pancreas and gastrointestinal tract. In: A lange medical book. Harperâ€™s text book of biochemistry; 1996. p. 557â€“72.
Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, Pollera M, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004;89:5535-41.
Pirot P, Naamane N, Libert F, Magnusson NE, Orntoft TF, Cardozo AK, et al. Global profiling of genes modified by endoplasmic reticulum stress in pancreatic beta cells reveals the early degradation of insulin mRNAs. Diabetologia 2007;50:1006-14.
Pribac G, Craciun C, Szoke-Nagy T, Simeoni I, Lang C, Rosioru C, et al. Comparative ultrastructural study of pancreatic beta cells from diabetic rats treated with Fenugreek seeds flour or Ganoderma flour. Ann Romanian Soc Cell Biol 2011;16:62.
Adeyemi DO, Komolafe OA, Adewole OS, Obuotor EM, Abiodun AA, Adenowo TK. Histomorphological and morphometric studies of the pancreatic islet cells of diabetic rats treated with extracts of Annona muricata. Folia Morphol 2010;69:92-100.
Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-90.
Li N, Brun T, Cnop M, Cunha DA, Eizirik DL, Maechler P. Transient oxidative stress damages mitochondrial machinery inducing persistent beta-cell dysfunction. J Biol Chem 2009;284:23602-12.
Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.
Robertson RP, Harmon JS. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radical Biol Med 2006;41:177-84.
Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006;212:167-78.
Piconi L, Quagliaro L, Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 2003;41:1144-9.
Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004;134:489-92.
Mastrocola R, Restivo F, Vercellinatto I, Danni O, Brignardello E, Aragno M, Boccuzzi G. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol 2005;187:37-44.
Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005;43:289-330.
Simmons RA. Developmental origins of diabetes: the role of oxidative stress. Free Radical Biol Med 2006;40:917-22.